![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RAB5C |
Gene summary for RAB5C |
![]() |
Gene information | Species | Human | Gene symbol | RAB5C | Gene ID | 5878 |
Gene name | RAB5C, member RAS oncogene family | |
Gene Alias | L1880 | |
Cytomap | 17q21.2 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | P51148 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5878 | RAB5C | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.41e-10 | 2.22e-01 | 0.0155 |
5878 | RAB5C | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.23e-33 | 8.00e-01 | -0.1808 |
5878 | RAB5C | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.22e-05 | 2.80e-01 | 0.0216 |
5878 | RAB5C | HTA11_1938_2000001011 | Human | Colorectum | AD | 8.28e-25 | 6.99e-01 | -0.0811 |
5878 | RAB5C | HTA11_78_2000001011 | Human | Colorectum | AD | 4.79e-18 | 4.23e-01 | -0.1088 |
5878 | RAB5C | HTA11_347_2000001011 | Human | Colorectum | AD | 5.41e-38 | 6.61e-01 | -0.1954 |
5878 | RAB5C | HTA11_411_2000001011 | Human | Colorectum | SER | 2.50e-11 | 9.77e-01 | -0.2602 |
5878 | RAB5C | HTA11_2112_2000001011 | Human | Colorectum | SER | 1.88e-13 | 9.02e-01 | -0.2196 |
5878 | RAB5C | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.01e-23 | 5.98e-01 | -0.1207 |
5878 | RAB5C | HTA11_83_2000001011 | Human | Colorectum | SER | 6.65e-20 | 5.21e-01 | -0.1526 |
5878 | RAB5C | HTA11_696_2000001011 | Human | Colorectum | AD | 1.09e-36 | 6.04e-01 | -0.1464 |
5878 | RAB5C | HTA11_866_2000001011 | Human | Colorectum | AD | 1.44e-19 | 3.45e-01 | -0.1001 |
5878 | RAB5C | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.53e-27 | 6.66e-01 | -0.059 |
5878 | RAB5C | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.52e-10 | 4.65e-01 | -0.1706 |
5878 | RAB5C | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.44e-09 | 5.32e-01 | -0.2061 |
5878 | RAB5C | HTA11_5216_2000001011 | Human | Colorectum | SER | 1.51e-11 | 5.62e-01 | -0.1462 |
5878 | RAB5C | HTA11_546_2000001011 | Human | Colorectum | AD | 4.04e-11 | 4.42e-01 | -0.0842 |
5878 | RAB5C | HTA11_9341_2000001011 | Human | Colorectum | SER | 4.01e-04 | 3.31e-01 | -0.00410000000000005 |
5878 | RAB5C | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.67e-07 | 3.05e-01 | -0.0179 |
5878 | RAB5C | HTA11_866_3004761011 | Human | Colorectum | AD | 1.19e-25 | 4.96e-01 | 0.096 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0030100 | Colorectum | AD | regulation of endocytosis | 67/3918 | 211/18723 | 1.42e-04 | 2.01e-03 | 67 |
GO:00301001 | Colorectum | SER | regulation of endocytosis | 48/2897 | 211/18723 | 3.29e-03 | 2.82e-02 | 48 |
GO:00301002 | Colorectum | MSS | regulation of endocytosis | 63/3467 | 211/18723 | 4.05e-05 | 7.66e-04 | 63 |
GO:00301009 | Endometrium | AEH | regulation of endocytosis | 44/2100 | 211/18723 | 3.39e-05 | 6.05e-04 | 44 |
GO:003010014 | Endometrium | EEC | regulation of endocytosis | 45/2168 | 211/18723 | 3.40e-05 | 5.78e-04 | 45 |
GO:003010018 | Esophagus | ESCC | regulation of endocytosis | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
GO:003010011 | Liver | Cirrhotic | regulation of endocytosis | 74/4634 | 211/18723 | 4.86e-04 | 3.90e-03 | 74 |
GO:003010021 | Liver | HCC | regulation of endocytosis | 117/7958 | 211/18723 | 9.56e-05 | 8.32e-04 | 117 |
GO:003010016 | Oral cavity | OSCC | regulation of endocytosis | 121/7305 | 211/18723 | 4.74e-08 | 8.80e-07 | 121 |
GO:003010017 | Oral cavity | LP | regulation of endocytosis | 81/4623 | 211/18723 | 6.57e-06 | 1.29e-04 | 81 |
GO:003010019 | Skin | AK | regulation of endocytosis | 36/1910 | 211/18723 | 1.42e-03 | 1.05e-02 | 36 |
GO:003010024 | Skin | cSCC | regulation of endocytosis | 72/4864 | 211/18723 | 5.06e-03 | 2.56e-02 | 72 |
GO:003010020 | Thyroid | PTC | regulation of endocytosis | 108/5968 | 211/18723 | 3.92e-09 | 1.04e-07 | 108 |
GO:0030100111 | Thyroid | ATC | regulation of endocytosis | 113/6293 | 211/18723 | 1.71e-09 | 4.22e-08 | 113 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04144 | Colorectum | AD | Endocytosis | 111/2092 | 251/8465 | 5.95e-12 | 1.42e-10 | 9.08e-11 | 111 |
hsa05132 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
hsa04962 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
hsa041441 | Colorectum | AD | Endocytosis | 111/2092 | 251/8465 | 5.95e-12 | 1.42e-10 | 9.08e-11 | 111 |
hsa051321 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
hsa049621 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
hsa041442 | Colorectum | SER | Endocytosis | 81/1580 | 251/8465 | 1.14e-07 | 2.36e-06 | 1.71e-06 | 81 |
hsa051322 | Colorectum | SER | Salmonella infection | 77/1580 | 249/8465 | 1.56e-06 | 2.35e-05 | 1.71e-05 | 77 |
hsa041443 | Colorectum | SER | Endocytosis | 81/1580 | 251/8465 | 1.14e-07 | 2.36e-06 | 1.71e-06 | 81 |
hsa051323 | Colorectum | SER | Salmonella infection | 77/1580 | 249/8465 | 1.56e-06 | 2.35e-05 | 1.71e-05 | 77 |
hsa041444 | Colorectum | MSS | Endocytosis | 102/1875 | 251/8465 | 1.85e-11 | 4.43e-10 | 2.71e-10 | 102 |
hsa051324 | Colorectum | MSS | Salmonella infection | 92/1875 | 249/8465 | 5.23e-08 | 9.74e-07 | 5.97e-07 | 92 |
hsa049622 | Colorectum | MSS | Vasopressin-regulated water reabsorption | 17/1875 | 44/8465 | 9.76e-03 | 3.55e-02 | 2.18e-02 | 17 |
hsa041445 | Colorectum | MSS | Endocytosis | 102/1875 | 251/8465 | 1.85e-11 | 4.43e-10 | 2.71e-10 | 102 |
hsa051325 | Colorectum | MSS | Salmonella infection | 92/1875 | 249/8465 | 5.23e-08 | 9.74e-07 | 5.97e-07 | 92 |
hsa049623 | Colorectum | MSS | Vasopressin-regulated water reabsorption | 17/1875 | 44/8465 | 9.76e-03 | 3.55e-02 | 2.18e-02 | 17 |
hsa0513226 | Endometrium | AEH | Salmonella infection | 71/1197 | 249/8465 | 1.69e-09 | 3.44e-08 | 2.52e-08 | 71 |
hsa0414524 | Endometrium | AEH | Phagosome | 41/1197 | 152/8465 | 2.12e-05 | 2.22e-04 | 1.63e-04 | 41 |
hsa051466 | Endometrium | AEH | Amoebiasis | 29/1197 | 102/8465 | 1.22e-04 | 1.10e-03 | 8.06e-04 | 29 |
hsa0414420 | Endometrium | AEH | Endocytosis | 56/1197 | 251/8465 | 2.58e-04 | 2.15e-03 | 1.57e-03 | 56 |
Page: 1 2 3 4 5 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RAB5C | SNV | Missense_Mutation | rs757729852 | c.616G>A | p.Glu206Lys | p.E206K | P51148 | protein_coding | deleterious(0.02) | benign(0.244) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
RAB5C | SNV | Missense_Mutation | novel | c.566A>G | p.Asn189Ser | p.N189S | P51148 | protein_coding | deleterious(0.02) | benign(0.175) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
RAB5C | SNV | Missense_Mutation | novel | c.308T>C | p.Val103Ala | p.V103A | P51148 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
RAB5C | SNV | Missense_Mutation | c.438G>T | p.Lys146Asn | p.K146N | P51148 | protein_coding | deleterious(0) | possibly_damaging(0.688) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RAB5C | SNV | Missense_Mutation | rs761919578 | c.128C>T | p.Pro43Leu | p.P43L | P51148 | protein_coding | deleterious(0) | benign(0.118) | TCGA-49-6743-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD |
RAB5C | SNV | Missense_Mutation | novel | c.217N>A | p.Arg73Ser | p.R73S | P51148 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-86-7701-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | etoposide | PD |
RAB5C | SNV | Missense_Mutation | rs752617266 | c.461N>A | p.Arg154Lys | p.R154K | P51148 | protein_coding | tolerated(0.19) | benign(0.021) | TCGA-92-7341-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RAB5C | SNV | Missense_Mutation | novel | c.238N>T | p.His80Tyr | p.H80Y | P51148 | protein_coding | tolerated(0.41) | benign(0.007) | TCGA-TN-A7HL-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR |
RAB5C | SNV | Missense_Mutation | rs767452695 | c.241N>A | p.Glu81Lys | p.E81K | P51148 | protein_coding | tolerated(0.08) | possibly_damaging(0.515) | TCGA-CH-5792-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | SD |
RAB5C | SNV | Missense_Mutation | c.300N>A | p.Asp100Glu | p.D100E | P51148 | protein_coding | tolerated(0.26) | benign(0.068) | TCGA-EJ-7123-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |